Rivaroxaban, a direct Factor Xa inhibitor, versus...

Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post–Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study)

Pina, Liza Miriam, Dong, Xiangwen, Zhang, Liping, Samtani, Mahesh N., Michelson, Alan D., Justino, Henri, Bonnet, Damien, Harris, Kevin C., Jefferies, John, McCrindle, Brian W., Li, Jennifer S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
213
Language:
english
Journal:
American Heart Journal
DOI:
10.1016/j.ahj.2019.04.009
Date:
July, 2019
File:
PDF, 243 KB
english, 2019
Conversion to is in progress
Conversion to is failed